BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24370825)

  • 1. TGF-β promotes glioma cell growth via activating Nodal expression through Smad and ERK1/2 pathways.
    Sun J; Liu SZ; Lin Y; Cao XP; Liu JM
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1066-72. PubMed ID: 24370825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lefty inhibits glioma growth by suppressing Nodal-activated Smad and ERK1/2 pathways.
    Sun G; Shi L; Li M; Jiang N; Fu L; Guo J
    J Neurol Sci; 2014 Dec; 347(1-2):137-42. PubMed ID: 25304053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
    Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
    Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-193b promotes cell proliferation by targeting Smad3 in human glioma.
    Zhong Q; Wang T; Lu P; Zhang R; Zou J; Yuan S
    J Neurosci Res; 2014 May; 92(5):619-26. PubMed ID: 24496888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
    Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
    Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
    Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta signaling via Ras in mesenchymal cells requires p21-activated kinase 2 for extracellular signal-regulated kinase-dependent transcriptional responses.
    Suzuki K; Wilkes MC; Garamszegi N; Edens M; Leof EB
    Cancer Res; 2007 Apr; 67(8):3673-82. PubMed ID: 17440079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-β)-induced Smad signaling in prostate cancer cells.
    Vo BT; Cody B; Cao Y; Khan SA
    Carcinogenesis; 2012 Nov; 33(11):2054-64. PubMed ID: 22843506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
    Schedlich LJ; Yenson VM; Baxter RC
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
    Yoo YA; Kang MH; Kim JS; Oh SC
    Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodal activates smad and extracellular signal-regulated kinases 1/2 pathways promoting renal cell carcinoma proliferation.
    Zhang Z; Jiang T; Li Q; Wang J; Yang D; Li X; Wang Q; Song X
    Mol Med Rep; 2015 Jul; 12(1):587-94. PubMed ID: 25672326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human eosinophils have an intact Smad signaling pathway leading to a major transforming growth factor-beta target gene expression.
    Kanzaki M; Shibagaki N; Hatsushika K; Mitsui H; Inozume T; Okamoto A; Dobashi Y; Ogawa H; Shimada S; Nakao A
    Int Arch Allergy Immunol; 2007; 142(4):309-17. PubMed ID: 17135762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways.
    Duan R; Han L; Wang Q; Wei J; Chen L; Zhang J; Kang C; Wang L
    Oncotarget; 2015 Sep; 6(29):27778-93. PubMed ID: 26356815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta regulates differentially the proliferation of fetal and adult human skin fibroblasts via the activation of PKA and the autocrine action of FGF-2.
    Giannouli CC; Kletsas D
    Cell Signal; 2006 Sep; 18(9):1417-29. PubMed ID: 16361081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of the transforming growth factor-β pathway by tolfenamic acid via the ERK MAP kinase pathway.
    Zhang X; Min KW; Liggett J; Baek SJ
    Carcinogenesis; 2013 Dec; 34(12):2900-7. PubMed ID: 23864386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad protein mediated transforming growth factor beta1 induction of apoptosis in the MDPC-23 odontoblast-like cell line.
    He WX; Niu ZY; Zhao SL; Smith AJ
    Arch Oral Biol; 2005 Nov; 50(11):929-36. PubMed ID: 16183370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma.
    Grzmil M; Morin P; Lino MM; Merlo A; Frank S; Wang Y; Moncayo G; Hemmings BA
    Cancer Res; 2011 Mar; 71(6):2392-402. PubMed ID: 21406405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta suppressed Id-1 Expression in a smad3-dependent manner in LoVo cells.
    Song H; Guo B; Zhang J; Song C
    Anat Rec (Hoboken); 2010 Jan; 293(1):42-7. PubMed ID: 19798702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.
    Matsuzaki K; Kitano C; Murata M; Sekimoto G; Yoshida K; Uemura Y; Seki T; Taketani S; Fujisawa J; Okazaki K
    Cancer Res; 2009 Jul; 69(13):5321-30. PubMed ID: 19531654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.